member of DURATION-1 Study Group
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
.
Lancet (London, England).
2008
Contact
full name
member of DURATION-1 Study Group
Quick Info
Collaboration
Co-author network
Map of science